Dihydroergocristine mesylate

Discontinued Product

Dihydroergocristine mesylate (Cat. No. 0474) has been withdrawn from sale for commercial reasons.
Cat.No. 0474 - Dihydroergocristine mesylate | C35H41N5O5.CH3SO3H | CAS No. 24730-10-7
Description: α partial agonist
Chemical Name: (5'α,10α)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione mesylate
Purity: ≥98% (HPLC)
Literature (4)

Biological Activity for Dihydroergocristine mesylate

Dihydroergocristine mesylate is a 5-HT receptor antagonist; partial agonist at adrenergic and dopaminergic receptors.

Technical Data for Dihydroergocristine mesylate

M. Wt 707.84
Formula C35H41N5O5.CH3SO3H
Storage Store at RT
Purity ≥98% (HPLC)
CAS Number 24730-10-7
PubChem ID 444034
Smiles CS(=O)(O)=O.[H][C@]4([C@@]([H])3C[C@@H]([C@@](N[C@@]5([C@H](C)C)C(N([C@@]([H])(CC8=CC=CC=C8)C(N7[C@]([H])6CCC7)=O)[C@@]6(O)O5)=O)=O)CN4C)CC1=CNC2=C1C3=CC=C2

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Dihydroergocristine mesylate

References for Dihydroergocristine mesylate

References are publications that support the biological activity of the product.

Drago (1988) Dihydroergocristine and memory alterations of aged male rats. Pharmacol.Biochem.Behav. 30 961 PMID: 3147464

View Related Products by Product Action

View all Non-selective Adrenergic α Receptor Agonists

Keywords: Dihydroergocristine mesylate, Dihydroergocristine mesylate supplier, Partial, α-adrenoceptors, α-adrenoceptor, alpha-adrenoceptors, agonists, Non-Selective, dopamine, receptors, partial, α-adrenergic, alpha-adrenergic, a-adrenergic, 5-HT, antagonists, dopaminergic, D2-like, 5-Hydroxytryptamine, Serotonin, 5-HT3, Non-selective, Adrenergic, Alpha, Receptors, Dopamine, 0474, Tocris Bioscience

Citations for Dihydroergocristine mesylate

Citations are publications that use Tocris products.

Currently there are no citations for Dihydroergocristine mesylate.

Reviews for Dihydroergocristine mesylate

There are currently no reviews for this product. Be the first to review Dihydroergocristine mesylate and earn rewards!

Have you used Dihydroergocristine mesylate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cardiovascular Research Product Guide

Cardiovascular Research Product Guide

A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:

  • Hypertension
  • Thrombosis and Hemostasis
  • Atherosclerosis
  • Myocardial Infarction
  • Ischemia/Reperfusion Injury
  • Arrhythmias
  • Heart Failure
GPCR Product Listing

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Cardiovascular Poster

Cardiovascular Poster

Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.